Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Electrophoresis|January 22, 2013
von Willebrand Factor multimers profiling with a semi-automated systemFabio Pasotti, Giuliana Martini, Luigi Caimi, et al.Clinical Chemistry and Laboratory Medicine|April 10, 2002
Plasma total antioxidant capacity in hemodialyzed patients and its relationships to other biomarkers of oxidative stress and lipid peroxidationGianMario Gerardi, Mario Usberti, Giuliana Martini, et al.Journal of Extracellular Biology|June 28, 2024
Active antithrombin glycoforms are selectively physiosorbed on plasma extracellular vesiclesAnnalisa Radeghieri, Silvia Alacqua, Andrea Zendrini, et al.Journal of the Neurological Sciences|March 12, 2005
Cholinesterase inhibitors exert a protective effect on endothelial damage in Alzheimer disease patientsBarbara Borroni, Chiara Agosti, Giuliana Martini, et al.Blood Reviews|September 2, 2020
Coagulation dysfunction in COVID-19: The interplay between inflammation, viral infection and the coagulation systemMaria Grazia Lazzaroni, Silvia Piantoni, Stefania Masneri, et al.Medicine|December 30, 2016
VKORC1 and CYP2C9 polymorphisms related to adverse events in case-control cohort of anticoagulated patientsSilvia Misasi, Giuliana Martini, Oriana Paoletti, et al.Cytometry. Part B, Clinical Cytometry|March 3, 2004
New laboratory test in flow cytometry for the combined analysis of serologic and cellular parameters in the diagnosis of heparin-induced thrombocytopeniaGiuliana Gobbi, Prisco Mirandola, Pier Luigi Tazzari, et al.Biochemical Pharmacology|September 22, 2014
Oversulfated heparins with low anticoagulant activity are strong and fast inhibitors of hepcidin expression in vitro and in vivoMaura Poli, Michela Asperti, Paola Ruzzenenti, et al.Journal of the Neurological Sciences|November 6, 2002
Microvascular damage and platelet abnormalities in early Alzheimer's diseaseBarbara Borroni, Nabil Akkawi, Giuliana Martini, et al.Clinical Immunology (Orlando, Fla.)|January 21, 2024
The prevalence and incidence of thrombotic primary antiphospholipid syndrome in adults aged 18-49 years: A population-based study in a mountain community in northern ItalyLaura Andreoli, Cecilia Nalli, Elena Raffetti, et al.Pageof 2